Vifor Pharma
- Business Wire
Abbas Hussain Appointed as New Chief Executive Officer of Vifor Pharma
Abbas Hussain will take over as CEO of the Vifor Pharma Group on 16 August 2021 Succeeding Stefan Schulze, who…
Read More » - Business Wire
Vifor Pharma and Angion announce completion of enrollment in phase-II study of ANG-3777 for cardiac-surgery associated acute kidney injury
Topline data expected in the second half of 2021 ST. GALLEN, Switzerland & UNIONDALE, NY–(BUSINESS WIRE)–Regulatory News: Vifor Pharma and…
Read More » - Business Wire
First patient enrolled in CARE-HK in HF to evaluate role of Veltassa® (patiromer) in enabling RAASi treatment
CARE-HK in heart failure (HF) is the first global registry of around 5,000 patients with chronic HF who have or…
Read More » - Business
Vifor Pharma to propose Dr Alexandre LeBeaut as Board member
St. Gallen, Switzerland: Dr Alexandre LeBeaut to be proposed to Annual General Meeting for appointment to Board Dr Gianni Zampieri…
Read More » - Health
Vifor Pharma supports Iron Deficiency Day 2020 to highlight global impact on health and gender inequality
St. Gallen, Switzerland: In its sixth year, a growing international coalition underlines significant harm to health caused by iron deficiency…
Read More » - Business
Full Results From AFFIRM-AHF Study Show Ferinject® Significantly Reduces Hospitalizations After Acute Heart Failure in Patients With Iron Deficiency
St. Gallen, Switzerland: Ferinject® significantly reduced the incidence of heart failure hospitalizations in patients with iron deficiency after acute heart failure…
Read More » - Business
Vifor Pharma and Angion Sign License Agreement for ANG-3777 in Nephrology Indications
St. Gallen, Switzerland & Uniondale, N.Y., United States: Vifor Pharma acquires a worldwide license, excluding Greater China, to late-stage product ANG-3777 ANG-3777 is…
Read More » - United States
VFMCRP and ChemoCentryx announce European Medicines Agency has accepted to review the Marketing Authorization Application for avacopan
St. Gallen, Switzerland & Mountain View, Calif., United States: Companies have completed the EU regulatory application for marketing approval of…
Read More » -
Vifor Pharma and Cara Therapeutics sign US license agreement for i.v. Korsuva™* to treat dialysis patients with pruritus
St. Gallen, Switzerland & Stamford, Conn., United States: Vifor Pharma secures US commercial rights for i.v. Korsuva in non-Fresenius Medical…
Read More » - World
Vifor Pharma Appoints Gregory Oakes as President North America and Member of the Executive Committee
St. Gallen, Switzerland: Regulatory News: Vifor Pharma today announced the appointment of Gregory Oakes as EVP, President North America and…
Read More »